SCHEMBL7597312

SCHEMBL7597312

CCOC(=O)Cn1c(=O)c2c(CNS(C)(=O)=O)c(-c3ccc(OCC(=O)O)cc3)sc2n(Cc2ccccc2SC)c1=O

nearest known ligand 0.36

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
GNRHR P30968 5/20 0.36
ALDH1A1 P00352 3/20 0.33
LMNA P02545 2/20 0.33
EDNRB P24530 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TP53 P04637 1/20 0.32
ADORA2B P29275 2/20 0.32
PTPN1 P18031 1/20 0.32
FFAR4 Q5NUL3 1/20 0.32
ADORA2A P29274 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7598723 0.93 GNRHR (0.36) MEN1KMT2AGNRHRALDH1A1LMNA
SCHEMBL7593455 0.93 GNRHR (0.36) MEN1KMT2AGNRHRALDH1A1LMNA
SCHEMBL7592912 0.92 GNRHR (0.37) MEN1KMT2AGNRHRALDH1A1LMNA
SCHEMBL7596779 0.92 GNRHR (0.43) MEN1KMT2AGNRHREDNRB
SCHEMBL7597198 0.91 NPSR1 (0.37) MEN1KMT2AGNRHRALDH1A1LMNA
SCHEMBL7594581 0.91 GNRHR (0.35) MEN1KMT2AGNRHRALDH1A1LMNA
SCHEMBL7597705 0.90 MEN1 (0.37) MEN1KMT2AGNRHRALDH1A1LMNA
SCHEMBL7590037 0.88 GNRHR (0.34) KMT2AGNRHRLMNAEDNRBADORA3
SCHEMBL7595053 0.88 GNRHR (0.35) MEN1KMT2AGNRHREDNRB
SCHEMBL7594784 0.88 GNRHR (0.35) MEN1KMT2AGNRHREDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0846119-B1 THIENOPYRIMIDINE DERIVATIVES, THEIR PRODUCTION AND USE AS ENDOTHELIN ANTAGONISTS TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2002-11-13 EP disclosed
US-6140325-A HAS ENDOTHELIN ANTAGONISTIC ACTION; FOR TREATING LIVER HYPOFUNCTION, ACUTE RENAL INSUFFICIENCY, CARDIAC INFARCTION OR LIVER INSUFFICIENCY, VASOCONSTRICTION TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-10-31 US disclosed